Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Men With Hormone-refractory Prostate Cancer
==============================================================================================================

A new-user cohort study of denosumab vs. zoledronic acid to treat bone metastases in men with hormone-refractory prostate cancer. This study aims to replicate [this trial](https://clinicaltrials.gov/ct2/show/study/NCT00321620).


# How to run

...

# Development status

Under development. Do not run